May 3, 2012
-- India is evincing a hallmark of excellence in the pharmaceutical sector. The Indian pharmaceutical market has been a global leader in providing high quality affordable medicines to the world and according to the latest reports by the Govt. of India, there is a growth of approximately 17% and the market is currently worth about US $137 billion, and it could be worth US $319 billion by 2020. Indian companies are cognizant of the dominance of the developments in the technology. The industry is making tremendous progress in the R&D against the dreadful diseases like HIV, TB, Cancer and heart diseases. There is a paradigm shift in the innovations and the technological know-how.
To boost the industry outlook, Fleming India is organising a conference on “BioPharma-
India Today to Future 2020 on 10th & 11th October, 2012, in Mumbai. The conference will highlight the Indian scenario towards vision 2020 in the Bio-Pharma industry and will address key challenges and opportunities to maximize commercial benefits to the industry at large. India has made remarkable advances in this sector and is bridging a gap between the present and the future in the terms of innovations. Delegates from leading pharma, biotech and Contract Manufacturing Organizations (CMO's) will be present to benefit from the forum.
Despite the challenges faced in the recent years, the Indian pharma sector is driving a breakthrough in innovation. An appropriate platform that can widen the scope of development is the need of the hour and the major pharma players are hoping to showcase their innovate solutions at the congregation
For more information visit:http://www.fleminggulf.com/conferenceview/Bio-Pharma-Indi...